Back to Clinical Trials

Brief Title: Dosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized Trial

An Adaptive Design for Dosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized Trial

INTRODUCTION

  • Org Study ID: PRO00055140
  • Secondary ID: N/A
  • NCT ID: NCT07227077
  • Sponsor: Medical College of Wisconsin

BRIEF SUMMARY

The purpose of this study is to assess the best time to deliver a message to increase physical activity and how often participants will experience a pain episode in the 24 hours following their receipt of a message to increase physical activity.

DETAILED DESCRIPTION

The primary objective of this study is to test a theory-based, micro-randomized trial to determine the optimal state to deliver a message to increase physical activity by determining the probability older cancer survivors will be physically active in the one hour following a messaging prompt. The secondary, exploratory objective is to determine the probability older cancer survivors will experience a pain episode in the 24 hours following their receipt of a message to increase physical activity.

Eligibility criteria is deliberately incomplete to preserve the scientific integrity of the study.

  • Overall Status
    Recruiting
  • Start Date
    March, 2026
  • Phase
    Not Applicable
  • Study Type
    Interventional

PRIMARY OUTCOMES

Primary Outcome 1 - Measure: ActiGraph accelerometer measured physical activity behaviors (sedentary

Primary Outcome 1 - Timeframe: 4 weeks

Primary Outcome 2 - Measure: light

Primary Outcome 2 - Timeframe: 4 weeks

Primary Outcome 3 - Measure: moderate

Primary Outcome 3 - Timeframe: N/A

Primary Outcome 4 - Measure: vigorous intensity).

Primary Outcome 4 - Timeframe: N/A

Primary Outcome 5 - Measure: 11-point box scale to assess pain on a scale of 0 (no pain) to 10 (worst possible pain).

Primary Outcome 5 - Timeframe: N/A

CONDITION

  • Breast Cancer
  • Cervical Cancer
  • Bladder Cancer
  • Colorectal Cancer
  • Endometrial Cancer
  • Lung Cancer
  • Prostate Cancer

ELIGIBILITY

Inclusion Criteria:
1. Age greater than or equal to 65 years.

- 2. Patients with a history of bladder, breast, cervical, colorectal, endometrial, lung, and prostate cancer diagnosis and treatment.

- 3. Fluent in spoken and written English.

- 4. Patient has access to smartphone

- 5. Ability to understand a written informed consent document, and the willingness to sign it.
Exclusion Criteria:
1. Patient has metastatic disease.

- 2. Patient has cancer recurrence.

Gender: All

Minimum Age: 65 Years

Maximum Age: N/A

Healthy Volunteers: No

OFFICIAL INFORMATION

Name: N/A

Role: N/A

Affiliation: N/A

Overall Contact

Name: Kelly Clohesey Clinical Research Coordinator, MOT, Whitney Morelli, PhD

Phone: 4149554099

Email: [email protected], [email protected]

LOCATION

Facility Status Contact
Facility: Froedtert Hospital
Milwaukee, Wisconsin 53226
United States
Status: Recruiting Contact: Contact
Kelly Clohesey Clinical Research Coordinator, MOT
414-801-6710
[email protected]

Principal Investigator
Whitney Morelli, Assistant Professor, PhD